India, April 21 -- The Supreme Court declined to interfere with a Bombay high court order reviving the Anti-Corruption Bureau (ACB) probe into an alleged Rs.2,000-crore disproportionate assets case in... Read More
Jhansi, April 21 -- Seldom is a man's integrity and honesty governed by economic standing or educational qualification. Proving the dictum true is Dharampal Ahirwar, 35, a simple e-rickshaw driver in ... Read More
New Delhi, April 21 -- In a significant reshuffle within the Adani group, Adani Power has emerged as the most valuable publicly listed company in the conglomerate, surpassing Adani Ports & SEZ. This ... Read More
नई दिल्ली, अप्रैल 21 -- जर्मनी के एक गुरुद्वारे में कुछ ऐसा बवाल हुआ कि लग रहा था कोई दंगा हो गया है। यहां दुइसबर्ग इलाके में गुरुद्वारा सिंह सभा में दो गुटों में हिंसा शुरू हो गई। जानकारी के मुताबिक ... Read More
UDHAMPUR, April 21 -- During routine traffic checking at Zero Morh Rehambal, a police party of PS Rehambal apprehended a suspicious person who attempted to flee on noticing the presence of police team... Read More
JAMMU, April 21 -- In a significant medical achievement, the All-India Institute of Medical Sciences (AIIMS) Jammu has successfully performed a complex surgical procedure-Proximal Splenorenal Shunt (P... Read More
India, April 21 -- Four foreign wrestling coaches have been hired to guide the Indian team in the lead up to the 2026 Asian Games and with an eye on the 2028 Los Angeles Olympics. Georgian Emzarios S... Read More
Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 21 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 21 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More